| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Invagen Pharmaceuticals, Inc. serves as a 10% Owner at ATXI. Across recent SEC filings that breaks down to 0 buys and 1 sell.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 11, 2022 | ATXI Avenue Therapeutics, Inc. | 10% Owner | Sell | 388,888 | $7.71 | $2,999,882.03 | -100% |